Frankfurt
02.10.26 | 20:15
6,550 Euro
+3,15 % +0,200
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Nutriband marks five years on Nasdaq, warrants expire | 1 | Investing.com | ||
| Do | Nutriband Inc.: Nutriband Marks Five Years on Nasdaq - CEO Letter to Shareholders | 734 | GlobeNewswire (Europe) | Nutriband CEO Gareth Sheridan Congratulates Shareholders on Five-Year Nasdaq Listing Anniversary CEO letter reflects on five years of milestones since the Company's October 1, 2021 uplisting, as AVERSA... ► Artikel lesen | |
| Mi | NSE - NutriBand Inc. - 25, Notification of the removal from listing and registration of matured, redeemed or retired securities | 1 | SEC Filings | ||
| NUTRIBAND Aktie jetzt für 0€ handeln | |||||
| Di | Nutriband Inc.: Nutriband CEO Gareth Sheridan Featured in New Nick Shirley Documentary Confronting America's Opioid Crisis | 1 | GlobeNewswire (USA) | ||
| 25.09. | Nutriband Inc.: Nutriband Appoints Decorated Navy SEAL and Veterans Health Advocate Robert J. O'Neill to Advisory Board | 2 | GlobeNewswire (USA) | ||
| 23.09. | NutriBand Inc. - 8-K, Current Report | 3 | SEC Filings | ||
| 09.09. | Nutriband Inc.: Nutriband CEO, Gareth Sheridan to Attend the Nasdaq Life Sciences Advisory Board (LaB) Biotech Summit | 1 | GlobeNewswire (USA) | ||
| 08.09. | Nutriband Inc.: Nutriband Receives USPTO Notice of Publication of Commercial Brand Name Trademarks for Its Abuse Deterrent Fentanyl Patch | 208 | GlobeNewswire (Europe) | Nutriband has received a Notice of Publication from the United States Patent and Trademark Office (USPTO) for commercial brand name trademarks for its lead product, an abuse deterrent fentanyl transdermal... ► Artikel lesen | |
| 04.09. | NutriBand Inc. - 10-Q, Quarterly Report | 3 | SEC Filings | ||
| 22.06. | NutriBand Inc. - 8-K, Current Report | - | SEC Filings | ||
| 11.06. | NutriBand Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 18.05. | NutriBand Inc. - 10-K/A, Annual Report | 2 | SEC Filings | ||
| 29.04. | NutriBand Inc. - 10-K, Annual Report | - | SEC Filings | ||
| 22.04. | Nutriband Inc.: Nutriband CEO, Gareth Sheridan Discusses the US Fentanyl Crisis and Company Update on Latest Episode of the Jack Neel Podcast | 2 | GlobeNewswire (USA) | ||
| 07.04. | NutriBand Inc. - 8-K, Current Report | - | SEC Filings | ||
| 30.03. | Nutriband Inc.: Nutriband Selects Commercial Brand Name for Its Abuse Deterrent Fentanyl Patch | 441 | GlobeNewswire (Europe) | Nutriband has selected the commercial worldwide brand name for its lead product, an abuse deterrent fentanyl transdermal system, and will submit to the FDA for approval per FDA Guidance. Nutriband... ► Artikel lesen | |
| 30.01. | Nutriband Inc. provides summary of Annual Shareholder Meeting Key Discussion Points | 264 | GlobeNewswire (Europe) | ORLANDO, Fla., Jan. 30, 2026 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW) has provided an update to shareholders on the key milestones and discussions from this years Annual Shareholders... ► Artikel lesen | |
| 31.12.25 | Nutriband Inc.: Nutriband CEO Publishes Letter to Shareholders | 333 | GlobeNewswire (Europe) | ORLANDO, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- Nutriband Inc. (NASDAQ:NTRB) (NASDAQ:NTRBW) today announced that CEO Gareth Sheridan has published a letter to shareholders providing insights on achievements... ► Artikel lesen | |
| 29.12.25 | Nutriband Inc. Signs Agreement to Sell Majority Stake of Subsidiary Pocono Pharmaceutical for $5M USD to EarthVision Bio | 809 | GlobeNewswire (Europe) | Earthvision Bio, is currently developing and commercializing its line of sustainable products developed by Dr. Gordon Moore, the founder of Intel, and Dr. Hans Franke, ex-chairman for Chevron Europe... ► Artikel lesen | |
| 24.11.25 | Noble Financial Group, Inc.: Nutriband Inc. To Present at The 2025 Noble Capital Markets Emerging Growth Equity Conference | 263 | Newsfile | Orlando, Florida--(Newsfile Corp. - November 24, 2025) - Nutriband Inc. (NASDAQ: NTRB) (NASDAQ: NTRBW), today announced that its Chairman and Co-Founder, Serguei Melnik will present at NobleCon21 -... ► Artikel lesen |
1 2 Weiter >>
21 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAYER | 44,940 | -1,01 % | 90 Milliarden US-Dollar bis 2030: Wie Bayer, Mesoblast und NurExone regenerative Medizin unterschiedlich entwickeln | ||
| NOVO NORDISK | 33,210 | -0,48 % | Novo Nordisk gerät trotz GLP-1 unter Druck - warum Eli Lilly und Co. schon Milliarden in neue Plattformen investieren | ||
| PFIZER | 24,735 | +0,18 % | Litfulo and tilrekimig data bolster Pfizer's immunology plans | ||
| GILEAD SCIENCES | 128,68 | +0,09 % | Assembly Biosciences: Herpes-Countdown mit Gilead | ||
| GSK | 20,870 | -1,04 % | JEFFERIES stuft GSK auf 'Buy' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat die Einstufung für GSK mit einem Kursziel von 2500 Pence auf "Buy" belassen. B7H3-Antikörper seien eine der am meisten unterschätzten Chancen... ► Artikel lesen | |
| ELI LILLY | 1.019,20 | +0,33 % | Eli Lilly's Jaypirca gains additional indication for untreated leukemia, lymphoma | ||
| ROCHE | 371,74 | -0,04 % | Roche will schneller forschen | BASEL (dpa-AFX) - Roche hat sich für die kommenden Jahre ehrgeizige Ziele gesetzt: Der Pharmakonzern will bis 2030 insgesamt 20 neue, besonders wirkungsvolle Medikamente hervorbringen und zugleich... ► Artikel lesen | |
| MERCK & CO | 128,18 | 0,00 % | AstraZeneca-Summit, Novo-Hengrui, Merck-Fierce Pharma Asia | ||
| TILRAY BRANDS | 3,215 | +0,31 % | Tilray Brands, Inc.: BrewDog Builds Momentum for Next Growth Chapter with Expanded Senior Leadership Team | New appointments strengthen marketing, hospitality, category, and international commercial leadership as BrewDog advances long-term growth under Tilray BrandsELLON, Scotland and LONDON, Sept. 28, 2026... ► Artikel lesen | |
| TEVA PHARMACEUTICAL INDUSTRIES | 34,600 | -1,14 % | XFRA TEVA: AUSSETZUNG/SUSPENSION | DAS/ DIE FOLGENDE(N) INSTRUMENT(E) IST/ SIND AB SOFORT AUSGESETZT:THE FOLLOWING INSTRUMENT(S) IS/ ARE SUSPENDED WITH IMMEDIATE EFFECT:INSTRUMENT NAME KUERZEL/SHORTCODE ISIN BIS/UNTILTEVA PHARMACEUT.... ► Artikel lesen | |
| VERTEX PHARMACEUTICALS | 448,45 | +0,04 % | $100 Invested In Vertex Pharmaceuticals 10 Years Ago Would Be Worth This Much Today | ||
| INNOCAN PHARMA | 1,265 | -0,78 % | Innocan Pharma Corporation: VALITIC Expands Retail Industry Visibility Through Shoptalk Fall 2026 in Nashville, USA | HERZLIYA, Israel and CALGARY, Alberta, Sept. 29, 2026 /PRNewswire/ -- Innocan Pharma Corporation (CSE: INNO) (OTCQB: INNPF) ("Innocan" or the "Company"), through B.I. Sky Global Ltd., its consumer... ► Artikel lesen | |
| TAAT GLOBAL ALTERNATIVES | 0,136 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM BOERSE FRANKFURT - 02.10.2026 -2- | The following instruments on Boerse Frankfurt do have their last trading day on 02.10.2026Die folgenden Instrumente in Boerse Frankfurt haben ihren letzten Handelstag am 02.10.2026ISIN NameCA83013Q8719 CORE... ► Artikel lesen | |
| BIOTEST | 33,200 | 0,00 % | Osborne Clarke berät Grifols S.A. bei der Umwandlung der Biotest AG in eine GmbH & Co. KGaA | ||
| NOVERIS HEALTH SCIENCES | 0,043 | +24,64 % | Noveris Health Sciences Inc.: Noveris Health Sciences Announces Results of 2026 Annual General and Special Meeting | Vancouver, British Columbia--(Newsfile Corp. - September 9, 2026) - Noveris Health Sciences Inc. (CSE: NVRS) (FSE: 0NF1) (OTC Pink: MYCOF) (the "Company" or "Noveris") announces the results of its annual... ► Artikel lesen |
NUTRIBAND INC gehört der Branche Pharma an. Der aktuelle Kurs liegt bei 6,550 Euro und damit +3,15 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu NUTRIBAND INC finden Sie auf Wallstreet Online.